Hainan Huluwa Pharmaceutical Group Co., Ltd.
public_traded
Hainan Huluwa Pharmaceutical Group Co., Ltd. is publicly traded on SHH under ticker 605199.SS.
Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China.